Sleeping during the day: Effects on the 24-h patterns of IGF-binding protein 1, insulin, glucose, cortisol, and growth hormone

European Journal of Endocrinology

Volumn 163, Issue 3, 2010, Pages 383-390

  Rehman, Javaid Ur ^a   Brismar, Kerstin ^a   Holmbäck, Ulf ^b   Åkerstedt, Torbjörn ^c   Axelsson, John ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE; HYDROCORTISONE; INSULIN; SOMATOMEDIN BINDING PROTEIN 1;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; INSULIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SLEEP;

ADULT; BLOOD GLUCOSE; CIRCADIAN RHYTHM; FASTING; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; MALE; SLEEP; SLEEP DISORDERS; TIME FACTORS; WAKEFULNESS; YOUNG ADULT;

EID: 77956276347     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0297     Document Type: Article

References (30)

1. Akerstedt T & Nilsson PM. Sleep as restitution: an introduction. Journal of Internal Medicine 2003 254 6-12. (doi:10.1046/j.1365-2796.2003.01195. x)
2. Eguchi K, Pickering TG, Schwartz JE, Hoshide S, Ishikawa J, Ishikawa S, Shimada K & Kario K. Short sleep duration as an independent predictor of cardiovascular events in Japanese patients with hypertension. Archives of Internal Medicine 2008 168 2225-2231. (doi:10.1001/archinte.168.20.2225)
3. Van Cauter E, Holmback U, Knutson K, Leproult R, Miller A, Nedeltcheva A, Pannain S, Penev P, Tasali E & Spiegel K. Impact of sleep and sleep loss on neuroendocrine and metabolic function. Hormone Research 2007 67 (Supplement 1) 2-9. (doi:10.1159/000097543) (Pubitemid 46272268)
4. Holly J & Perks C. The role of insulin-like growth factor binding proteins. Neuroendocrinology 2006 83 154-160. (doi:10.1159/000095523) (Pubitemid 44578867)
5. Brismar K, Hilding A & Lindgren B. Regulation of IGFBP-1 in humans. Progress in Growth Factor Research 1995 6 449-456. (doi:10.1016/0955-2235(96) 00006-3)
6. Conover CA, Divertie GD & Lee PD. Cortisol increases plasma insulin-like growth factor binding protein-1 in humans. Acta Endocrinologica 1993 128 140-143. (doi:10.1530/acta.0.1280140)
7. Lewitt MS, Hall K, Bang P & Brismar K. Altered response of insulin-like growth factor-binding protein 1 to nutritional deprivation in type 2 diabetes mellitus. Metabolism 2005 54 275-280. (doi:10.1016/j.metabol.2004.09. 005)
8. Busby WH, Snyder DK & Clemmons DR. Radioimmunoassay of a 26,000-dalton plasma insulin-like growth factor-binding protein: control by nutritional variables. Journal of Clinical Endocrinology and Metabolism 1988 67 1225-1230. (doi:10.1210/jcem-67-6-1225)
9. Rechtschaffen A & Kales A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Bethesda: US Department of Health, Education and Welfare, Public Health Service, 1968.
10. Axelsson J, Ingre M, Akerstedt T & Holmback U. Effects of acutely displaced sleep on testosterone. Journal of Clinical Endocrinology and Metabolism 2005 90 4530-4535. (doi:10.1210/jc.2005-0520) (Pubitemid 41159338)
11. Póvoa G, Roovete A & Hall K. Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinologica 1984 107 563-570. (doi:10.1530/acta.0.1070563) (Pubitemid 15216173)
12. Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Manson JE, Speizer FE & Hennekens CH. Prospective study of shift work and risk of coronary heart disease in women. Circulation 1995 92 3178-3182.
13. Koller M, Kundi M & Cervinka R. Field studies of shift work at an Austrian oil refinery. I. Health and psychosocial wellbeing of workers who drop out of shiftwork. Ergonomics 1978 21 835-847. (doi:10.1080/00140137808931787)
14. Lewitt MS, Hilding A, Ostenson CG, Efendic S, Brismar K & Hall K. Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men. Diabetologia 2008 51 1135-1145. (doi:10.1007/s00125-008-1016-x)
15. Heald AH, Anderson SG, Ivison F, Laing I, Gibson JM & Cruickshank K. C-reactive protein and the insulin-like growth factor (IGF)-system in relation to risk of cardiovascular disease in different ethnic groups. Atherosclerosis 2003 170 79-86. (doi:10.1016/S0021-9150(03)00235-1) (Pubitemid 37083566)
16. Katz LE, Satin-Smith MS, Collett-Solberg P, Baker L, Stanley CA & Cohen P. Dual regulation of insulin-like growth factor binding protein-1 levels by insulin and cortisol during fasting. Journal of Clinical Endocrinology and Metabolism 1998 83 4426-4430. (doi:10.1210/jc.83.12.4426) (Pubitemid 29100147)
17. Brismar K, Grill V, Efendic S & Hall K. The insulin-like growth factor binding protein-1 in low and high insulin responders before and during dexamethasone treatment. Metabolism 1991 40 728-732. (doi:10.1016/0026-0495(91) 90092-B)
18. Degerblad M, Povoa G, Thoren M, Wivall IL & Hall K. Lack of diurnal rhythm of low molecular weight insulin-like growth factor binding protein in patients with Cushing's disease. Acta Endocrinologica 1989 120 195-200. (doi:10.1530/acta.0.1200195) (Pubitemid 19049758)
19. Hilding A, Brismar K, Degerblad M, Thoren M & Hall K. Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects. Journal of Clinical Endocrinology and Metabolism 1995 80 2646-2652. (doi:10.1210/jc.80.9.2646)
20. Hall K, Lundin G & Povoa G. Serum levels of the low molecular weight form of insulin-like growth factor binding protein in healthy subjects and patients with growth hormone deficiency, acromegaly and anorexia nervosa. Acta Endocrinologica 1988 118 321-326. (doi:10.1530/acta.0.1180321)
21. Norrelund H, Fisker S, Vahl N, Borglum J, Richelsen B, Christiansen JS & Jorgensen JO. Evidence supporting a direct suppressive effect of growth hormone on serum IGFBP-1 levels. Experimental studies in normal, obese and GH-deficient adults. Growth Hormone and IGF Research 1999 9 52-60. (doi:10.1054/ghir.1998.0087)
22. Brismar K, Gutniak M, Povoa G, Werner S & Hall K. Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitus. Journal of Endocrinological Investigation 1988 11 599-602.
23. Fowelin J, Attvall S, von Schenck H, Smith U, Lager I & Hall K. Regulation of insulin-like growth factor binding protein-1 (IGFBP-1) in insulin-dependent diabetes mellitus. Effects of hyper-glycaemia and insulin. Acta Diabetologica 1994 31 183-186. (doi:10.1007/BF00571948)
24. Weibel L, Follenius M, Spiegel K, Ehrhart J & Brandenberger G. Comparative effect of night and daytime sleep on the 24-hour cortisol secretory profile. Sleep 1995 18 549-556.
25. Weibel L & Brandenberger G. Disturbances in hormonal profiles of night workers during their usual sleep and work times. Journal of Biological Rhythms 1998 13 202-208. (doi:10.1177/074873098129000048) (Pubitemid 128477538)
26. Spiegel K, Leproult R, L'Hermite-Baleriaux M, Copinschi G, Penev PD & Van Cauter E. Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin. Journal of Clinical Endocrinology and Metabolism 2004 89 5762-5771. (doi:10.1210/jc.2004-1003) (Pubitemid 39518469)
27. Vgontzas AN, Bixler EO, Lin HM, Prolo P, Mastorakos G, Vela-Bueno A, Kales A & Chrousos GP. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. Journal of Clinical Endocrinology and Metabolism 2001 86 3787-3794. (doi:10.1210/jc.86.8.3787)
28. Deuschle M, Schweiger U, Weber B, Gotthardt U, Korner A, Schmider J, Standhardt H, Lammers CH & Heuser I. Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls. Journal of Clinical Endocrinology and Metabolism 1997 82 234-238. (doi:10.1210/jc.82.1.234)
29. Brismar K & Hall K. Clinical applications of IGFBP-1 and its regulation. Growth Regulation 1993 3 98-100.
30. Katz LE, Jawad AF, Ganesh J, Abraham M, Murphy K & Lipman TH. Fasting C-peptide and insulin-like growth factorbinding protein-1 levels help to distinguish childhood type 1 and type 2 diabetes at diagnosis. Pediatric Diabetes 2007 8 53-59. (doi:10.1111/j.1399-5448.2007.00236.x)